Mogamulizumab and Phenylephrine, Dexchlorpheniramine, and Codeine
Determining the interaction of Mogamulizumab and Phenylephrine, Dexchlorpheniramine, and Codeine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
Generic Name: codeine / dexchlorpheniramine / phenylephrine
Brand name: Pro-Red AC, Vanacof CD
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-Phenylephrine, Pyrilamine, and Chlophedianol Liquid
- Mogamulizumab-Phenylephrine, Thonzylamine, and Dextromethorphan Liquid
- Mogamulizumab-Phenylephrine/Carbetapentane/Guaifenesin Capsules
- Mogamulizumab-Phenylephrine/Pyrilamine/Dextromethorphan Syrup
- Mogamulizumab-Phenylhistine DH
- Mogamulizumab-Phenylhistine DH Expectorant
- Phenylephrine, Dexchlorpheniramine, and Codeine-Mogamulizumab-kpkc
- Phenylephrine, Dexchlorpheniramine, and Codeine-Mogamulizumab-kpkc Intravenous
- Phenylephrine, Dexchlorpheniramine, and Codeine-Molindone
- Phenylephrine, Dexchlorpheniramine, and Codeine-Mometasone (Oral Inhalation)
- Phenylephrine, Dexchlorpheniramine, and Codeine-Mometasone and Formoterol
- Phenylephrine, Dexchlorpheniramine, and Codeine-Mometasone and formoterol Inhalation